Figure S2. Overexpression of Kpnβ1 results in increased sensitivity to Cisplatin. Dose-response curves are shown after treatment of HeLa EGFP- and HeLa Kpnβ1-EGF-expressing cells with Cisplatin. (PPTX 42 kb
Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells...
Overexpression of HE4 suppresses cisplatin-mediated activation of p38 and ERK. (A) SKOV3-NV, SKOV3-C...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
Figure S3. p53 and p21 inhibition reduces and enhances CaSki EGFP and Kpnβ1-EGFP cell sensitivity to...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Figure S1. KPNA7 mRNA expression levels were determined in the indicated cancer or normal cell lines...
Table: HOXC11 KD downregulated genes. HOXC11 differentially expressed genes (DEGs) downregulated af...
Figure S2. KPNA7 knock-down induces a growth arrest phenotype in pancreatic and breast cancer cells....
GMP scores in cancer cell lines. (A) Correlation of IC50 values of CPT-11 between 57 SCC cell lines ...
ST6Gal-I mRNA expression levels after transfection for different time points analyzed in this study....
Table: HOXC11 KD upregulated genes. HOXC11 differentially expressed genes (DEGs) upregulated after ...
Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....
NF-κB escalated PIK3CA promoter activity in SP cells. Cisplatin and TNFα but not lithium chloride or...
Table S2. Changes in protein expression levels for each studied cancer stem cell marker following tr...
Figure S2. (A-B) The RNA levels of KLF4 and miR-32-5p were analysed by q-RT-PCR in prostate cancer c...
Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells...
Overexpression of HE4 suppresses cisplatin-mediated activation of p38 and ERK. (A) SKOV3-NV, SKOV3-C...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
Figure S3. p53 and p21 inhibition reduces and enhances CaSki EGFP and Kpnβ1-EGFP cell sensitivity to...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Figure S1. KPNA7 mRNA expression levels were determined in the indicated cancer or normal cell lines...
Table: HOXC11 KD downregulated genes. HOXC11 differentially expressed genes (DEGs) downregulated af...
Figure S2. KPNA7 knock-down induces a growth arrest phenotype in pancreatic and breast cancer cells....
GMP scores in cancer cell lines. (A) Correlation of IC50 values of CPT-11 between 57 SCC cell lines ...
ST6Gal-I mRNA expression levels after transfection for different time points analyzed in this study....
Table: HOXC11 KD upregulated genes. HOXC11 differentially expressed genes (DEGs) upregulated after ...
Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....
NF-κB escalated PIK3CA promoter activity in SP cells. Cisplatin and TNFα but not lithium chloride or...
Table S2. Changes in protein expression levels for each studied cancer stem cell marker following tr...
Figure S2. (A-B) The RNA levels of KLF4 and miR-32-5p were analysed by q-RT-PCR in prostate cancer c...
Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells...
Overexpression of HE4 suppresses cisplatin-mediated activation of p38 and ERK. (A) SKOV3-NV, SKOV3-C...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...